Figure 2.

Kaplan-Meier survival curves for glioma patients with high or low expression of miR-372. (A) The 5-year overall survival rate of all 128 glioma patients with high or low miR-372 expression; (B) The 5-year overall survival rate of 78 glioma patients with advanced pathological grades (Grade III~IV) in high or low miR-372 expression group; (C) The 5-year overall survival rate of 50 glioma patients with low pathological grades (Grade I~II) in high or low miR-372 expression group.